An assessment of 6 placebo-controlled clinical trials with one,134 full contributors concluded that cannabinoids (nabiximols, dronabinol, and THC/CBD) ended up connected with a greater regular enhancement over the Ashworth scale for spasticity in several sclerosis people in contrast with placebo, De